The content of this volume is designed to reach a wide audience, including those involved with relevant technologies such as electrophoresis and mass spectrometry, to those interested in how proteomics can benefit research. A wide range of techniques are discussed, each specifically designed to address different needs in proteomic analysis. The concluding chapter discusses the important issue related to handling large amounts of data accumulated in proteomic studies.
- Discusses proteomics in the postgenomic age
- Includes various strategies for quantitative proteomics
- Covers the role of MS in structural functional proteomics and proteomics in drug discovery and bioinformatics
Inhaltsverzeichnis
1;Cover ;1 2;Contents;6 3;Chapter 1. Proteomics in the Postgenomic Age;12 3.1;I. Introduction;12 3.2;II. Deciphering the Genome;14 3.3;III. Gene Expression Profiles;14 3.4;IV. A Niche for Proteomics;17 3.5;V. The Proteome: Greater than the Sum of its Parts;19 3.6;VI. Biological and Clinical Applications;26 3.7;VII. Proteomics Meets Cell Biology;27 3.8;VIII. Summary;29 3.9;References;29 4;Chapter 2. The Tools of Proteomics;36 4.1;I. Introduction;36 4.2;II. Ionization Methods;38 4.3;III. Mass Analyzers;46 4.4;IV. Sample Fractionation;54 4.5;V. Software Tools;57 4.6;VI. Conclusions;62 4.7;References;62 5;Chapter 3. Proteomic Analysis by Two-Dimensional Polyacrylamide Gel Electrophoresis;68 5.1;I. Introduction;68 5.2;II. Historical Development of 2D-PAGE;70 5.3;III. Limitations and Advances;73 5.4;IV. Protein Visualization Methods;76 5.5;V. Proteome Application of 2D-PAGE;84 5.6;VI. The Future;92 5.7;References;92 6;Chapter 4. High-Performance Separations and Mass Spectrometric Methods for High-Throughput Proteomics Using Accurate Mass Tags;96 6.1;I. Introduction;96 6.2;II. Proteome Measurement Technology and Applications;98 6.3;III. Technology Advances for Expanding Proteome Coverage;125 6.4;References;138 7;Chapter 5. Current Strategies for Quantitative Proteomics;144 7.1;I. Introduction;144 7.2;II. Quantitative Two-Dimensional Polyacrylamide Gel Electrophoresis;147 7.3;III. Metabolic Labeling Applications for Quantitative Proteomics;152 7.4;IV. Chemical Modification Strategies for Quantitative Proteome Measurements;159 7.5;V. Conclusions;167 7.6;References;168 8;Chapter 6. Proteome Analysis of Posttranslational Modifications;172 8.1;I. Introduction;172 8.2;II. Phosphorylation;174 8.3;III. Mass Spectral Identification of Phosphopeptides;186 8.4;IV. Glycosylation;192 8.5;V. Conclusions;201 8.6;References;202 9;Chapter 7. Mapping Protein Modifications with Liquid Chromatography-Mass Spectrometry and the SALSA Algorithm;206 9.1;I. Introduction;206 9.2;II. MS-MS Fragmenta
tion of Modified Peptides;207 9.3;III. SALSA: A Pattern Recognition Algorithm to Identify MS-MS Spectra for Modified Peptides;211 9.4;IV. Mapping Protein Modifications with SALSA;216 9.5;V. Comparison of SALSA with Other Software for Analysis of MS-MS Data;221 9.6;References;223 10;Chapter 8. Emerging Role of Mass Spectrometry in Structural and Functional Proteomics;228 10.1;I. Introduction;228 10.2;II. Application of ESI-MS in Structural and Functional Proteomics;234 10.3;III. Future Directions;251 10.4;References;253 11;Chapter 9. Application of Separation Technologies to Proteomics Research;260 11.1;I. Introduction;260 11.2;II. What Is Proteomics?;261 11.3;III. What Needs to Be Separated?;262 11.4;IV. Slab Gel Electophoresis, High-Performance Liquid Chromatography, or Capillary Electrophoresis?;263 11.5;V. Multidimensional Separations of Proteins;267 11.6;VI. On-Column HPLC and CE Protein Concentration;274 11.7;VII. Detection;275 11.8;VIII. Proteome Quantitation Strategies;277 11.9;IX. Conclusion;278 11.10;References;279 12;Chapter 10. Proteomics of Membrane Proteins;282 12.1;I. Introduction;282 12.2;II. Techniques;287 12.3;III. Applications: The Thylakoid Membrane Proteome;304 12.4;IV. Conclusions;314 12.5;References;315 13;Chapter 11. Proteomics in Drug Discovery;320 13.1;I. Introduction;320 13.2;II. The Complexity of Proteomic Analysis in Drug Discovery;322 13.3;III. Proteomic Strategies in Drug Discovery;323 13.4;IV. Quantification in Proteomic Studies;326 13.5;V. Applications;330 13.6;VI. Functional Proteomics Approach;331 13.7;VII. Future Trends in Proteomics;340 13.8;References;345 14;Chapter 12. From Clone to Crystal: Maximizing the Amount of Protein Samples for Structure Determination;354 14.1;I. Introduction;354 14.2;II. Technology Drives the Process;355 14.3;III. From Sequence to Solubility: The First Step;357 14.4;IV. Alternative Expression Systems;357 14.5;V. Screening for the Most Soluble Ortholog;358 14.6;VI. Cofactor Screens;358 14.7;VII. Solubili
ty Screens;359 14.8;VIII. From Solubility to Structure: The Second Step;359 14.9;IX. Conclusions;361 14.10;References;361 15;Chapter 13. Proteomics and Bioinformatics;364 15.1;I. Introduction;364 15.2;II. Bioinformatics Tools;366 15.3;III. Proteomics Tools;369 15.4;IV. Database Integration;376 15.5;V. Conclusions;377 15.6;References;378 16;AUTHOR INDEX;382 17;SUBJECT INDEX;414 18;Color Plate Section;430